December 6 (SeeNews) - Bulgarian pharmaceuticals producer Sopharma [BUL:SFA] said on Monday that its sales revenue decreased by 3% on the year in the first eleven months of 2021.
While the company's domestic sales rose by 21% year-on-year in the January-November period of 2021, exports fell by 15%, Sopharma said in a bourse filing.
In November alone, Sopharma's total sales went down 9% on an annual comparison basis, as domestic sales grew by 42%, whereas exports decreased by 25%.
As at 15:50 CET on Monday, shares in Sopharma traded flat at 4.44 levs ($2.57/2.27 euro) on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)